Early human studies. This label summarises the type of data; it is neither a recommendation to use nor a safety rating.
How we read studies and personal accounts ↗Identity
It is an isomer of delta-9 THC: the position of a double bond differs. It occurs in small quantities in the plant; many concentrated products are obtained through chemical transformation. A declared plant origin does not remove its psychoactive activity.
Terms associated with this entry: delta-8 THC, delta 8 THC, Δ8-tetrahydrocannabinol.
What a controlled trial adds
A 2025 trial with 19 adults compared delta-8, delta-9 and placebo using a randomised, double-blind design. It found psychoactive effects and cognitive or psychomotor impairment depending on the study condition. The lower potency observed did not mean an absence of effects comparable to delta-9.
A product sample raises a different question
A study of commercial products examined contents and labelling. It highlights an essential distinction: a molecule studied under controlled conditions and a product sold under its name are not automatically equivalent. An analysis applies to a particular sample; it does not certify every brand or future batch.
Harm signals are not universal percentages
The FDA has received reports including vomiting, confusion and loss of consciousness, as well as accidental childhood exposures. These reports matter for surveillance, but cannot calculate what proportion of all users will experience a problem. They also do not, by themselves, describe Spanish law.
What has been studied
Acute-effects trials do not, by themselves, demonstrate efficacy in treating a disease.
Risks and gaps
It can produce intoxication and impaired performance; perceiving it as milder does not guarantee safety.
Documented forms
| Edibles and liquids | The FDA documents these forms, with particular concern about presentations attractive to children. |
|---|
A molecule and a product are different things. Read about flowers, resins, oils, creams, capsules and vaping.
Experiences
Accounts collected in a survey of 521 respondents
Many described relaxation and less anxiety than with delta-9; memory and concentration difficulties also appeared.
Source for this account: Accounts collected in a survey of 521 respondents · Original language: en · 2022-01-04
A voluntary sample, also recruited through an industry business, without verification of each product. These are perceptions, not a randomised clinical comparison.
Conclusion
Human evidence allows us to move beyond rumour, but also requires abandoning the idea that delta-8 is risk-free.
Legal context
Read the Spain note and official sources. Absence from a cited list does not establish that a product is lawful.
Sources
- 5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC · Official body
- A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults · Human trial
- Commercial Delta-8 THC Products: an Analysis of Content and Labeling · Laboratory study
- Delta-8-THC: Delta-9-THC’s nicer younger sibling? · Survey
Source review: 2026-11-02. No external clinical review. Corrections: info@milnubes.com.